Biofrontera BFRI
NASDAQ BFRI
$1.48 0.00 (-0.16%)
As of: Aug 21, 2026 · 10:53 AM EDT

Biofrontera (BFRI) Gross Margin (2020 - 2026)

Biofrontera (BFRI) posted quarterly Gross Margin of 82.4% for Q4 2025, up 2437.0% year-over-year from 3.25% in Q4 2024, and up 16.5% quarter-over-quarter from 70.74% in Q3 2025.

Biofrontera (BFRI) Gross Margin (2020 - 2026) Analysis & Trends

Biofrontera's Gross Margin history runs 6 years deep, the most recent figure standing at 82.4% for Q4 2025.

  • In Q4 2025, Gross Margin rose 2437.0% year-over-year to 82.4%; the TTM figure through Dec 2025 stood at 73.71% (up 2356.0% YoY), while the FY2025 annual figure was 73.71%, up 2357.0% from the prior year.
  • Gross Margin for Q4 2025 stood at 82.4%, up from 70.74% in the prior quarter.
  • The five-year high for Gross Margin was 112.8% in Q4 2023, with the low at 72.27% in Q4 2022.
  • The 5-year median for Gross Margin is 76.57% (2025), against an average of 70.47%.
  • The sharpest annual moves came in 2022 and 2023: Gross Margin sank 17349 bps in 2022, then soared 18507 bps in 2023.
  • Biofrontera's Gross Margin stood at 101.22% in 2021, then slumped by 171 bps to 72.27% in 2022, then jumped by 256 bps to 112.8% in 2023, then plunged by 49 bps to 58.03% in 2024, then soared by 42 bps to 82.4% in 2025.
  • Business Quant data shows BFRI's Gross Margin at 82.4% in Q4 2025, 70.74% in Q3 2025, and 70.74% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 44.23 Bn 43.26 Bn - -
2 Teva Pharmaceutical Industries 43.43 Bn 39.78 Bn 2.15 Bn 51.98%
3 Zoetis 32.57 Bn 30.90 Bn 1.05 Bn 42.63%
4 Takeda Pharmaceutical 28.63 Bn 22.84 Bn 5.10 Bn 66.66%
5 United Therapeutics 22.28 Bn 19.61 Bn 683.80 Mn 87.30%
6 Viatris 18.85 Bn 17.96 Bn 1.46 Bn 38.77%
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn 97.58%
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn 58.33%
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Biofrontera 19.04 Mn 14.33 Mn 9.59 Mn 79.92%

Historic Data

Download Data
DateValue
Jun 30, 2026 79.92%
Dec 31, 2025 82.40%
Sep 30, 2025 70.74%
Jun 30, 2025 70.74%
Mar 31, 2025 61.95%
Dec 31, 2024 58.03%
Sep 30, 2024 45.88%
Jun 30, 2024 44.61%
Mar 31, 2024 47.98%
Dec 31, 2023 112.80%
Sep 30, 2023 98.93%
Jun 30, 2023 52.60%
Mar 31, 2023 47.93%
Dec 31, 2022 -72.27%
Sep 30, 2022 97.73%
Jun 30, 2022 96.59%
Mar 31, 2022 98.21%
Dec 31, 2021 101.22%
Sep 30, 2021 99.05%
Jun 30, 2021 97.69%